ACCESSION: MSBNK-SMB_Measured-HSA015P0128023
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 40
COMMENT: RAW_SPEC {'EL19_pos_2192': {'bp': 75259.0, 'sum': 541727.0}, 'EL23_pos_2072': {'bp': 34178.0, 'sum': 332844.0}, 'EL23_pos_2294': {'bp': 35975.0, 'sum': 348669.0}, 'EL24_pos_2203': {'bp': 38239.0, 'sum': 359788.0}, 'EL02_pos_2360': {'bp': 39443.0, 'sum': 464234.0}, 'EL23_pos_2239': {'bp': 48785.0, 'sum': 450008.0}, 'EL15_pos_2239': {'bp': 49534.0, 'sum': 449471.0}, 'EL19_pos_2252': {'bp': 51204.0, 'sum': 462191.0}, 'EL22_pos_2236': {'bp': 69765.0, 'sum': 558445.0}, 'EL07_pos_2173': {'bp': 48323.0, 'sum': 419424.0}, 'EL22_pos_2295': {'bp': 53957.0, 'sum': 499322.0}, 'EL17_pos_2218': {'bp': 54414.0, 'sum': 432238.0}, 'EL20_pos_2186': {'bp': 61050.0, 'sum': 455520.0}, 'EL02_pos_2245': {'bp': 73271.0, 'sum': 546311.0}, 'EL12_pos_2288': {'bp': 38334.0, 'sum': 395728.0}, 'EL05_pos_2215': {'bp': 44093.0, 'sum': 433457.0}, 'EL09_pos_2191': {'bp': 47974.0, 'sum': 391086.0}, 'EL02_pos_2299': {'bp': 51335.0, 'sum': 480251.0}, 'EL09_pos_2083': {'bp': 63666.0, 'sum': 472146.0}, 'EL04_pos_2173': {'bp': 68498.0, 'sum': 461934.0}, 'EL06_pos_2180': {'bp': 40125.0, 'sum': 436564.0}, 'EL21_pos_2223': {'bp': 57980.0, 'sum': 447084.0}, 'EL13_pos_2211': {'bp': 55989.0, 'sum': 444874.0}, 'EL10_pos_2251': {'bp': 37600.0, 'sum': 375535.0}, 'EL04_pos_2236': {'bp': 34702.0, 'sum': 375879.0}, 'EL14_pos_2432': {'bp': 28923.0, 'sum': 285920.0}, 'EL08_pos_2203': {'bp': 64315.0, 'sum': 455422.0}, 'EL10_pos_2191': {'bp': 56484.0, 'sum': 407518.0}, 'EL12_pos_2229': {'bp': 51671.0, 'sum': 441888.0}, 'EL11_pos_2192': {'bp': 47827.0, 'sum': 400284.0}, 'EL01_pos_2293': {'bp': 43204.0, 'sum': 422005.0}, 'EL20_pos_2306': {'bp': 34237.0, 'sum': 378043.0}, 'EL24_pos_2085': {'bp': 33459.0, 'sum': 371580.0}, 'EL14_pos_2258': {'bp': 64473.0, 'sum': 501061.0}, 'EL14_pos_2378': {'bp': 39572.0, 'sum': 391293.0}, 'EL18_pos_2239': {'bp': 55314.0, 'sum': 452442.0}, 'EL01_pos_2239': {'bp': 54175.0, 'sum': 447440.0}, 'EL14_pos_2318': {'bp': 47103.0, 'sum': 393207.0}, 'EL16_pos_2150': {'bp': 40086.0, 'sum': 404872.0}, 'EL08_pos_2263': {'bp': 48753.0, 'sum': 448878.0}}
COMMENT: RETENTION_TIME_STDEV 0.116
COMMENT: PRECURSOR_M/Z_RAW 128.107239
COMMENT: PRECURSOR_M/Z_STDEV 0.000033
COMMENT: PRECURSOR_IN_MS1 mz 128.106986; int 96.579; delta(ppm) 0.806348
COMMENT: PROPOSED_CHARGE_STATE +1; mz 129.110348; int 6.870; cor 0.697
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.118; C7H13NO; [M+H]+; delta(ppm) -0.118018
COMMENT: PROPOSED_MF MS-FINDER 3.515; C7H13NO; [M+H]+; delta(ppm) -0.120805
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.467; C7H13NO; [M+H]+; delta(ppm) -0.120805
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H13NO; [M+H]+; delta(ppm) -0.120805
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.058; C7H13NO; [M+H]+; delta(ppm) -0.120805
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.191; C5H11N4; [M+H]+; delta(ppm) 10.360102
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H13NO; [M+H]+; delta(ppm) -0.120805
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.833; KDISMIMTGUMORD-UHFFFAOYSA-N; [M+H]+; CC(=O)N1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.716; RJLKIAGOYBARJG-UHFFFAOYSA-N; [M+H]+; CC1CCCN(C1=O)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.684; VERUITIRUQLVOC-UHFFFAOYSA-N; [M+H]+; CCCCC1=NCCO1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.667; IVLICPVPXWEGCA-UHFFFAOYSA-N; [M+H]+; OC1C[N@@]2CC[C@H]1CC2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.550; PNZXMIKHJXIPEK-UHFFFAOYSA-N; [M+H]+; NC(=O)C1CCCCC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.540; SWGXDLRCJNEEGZ-UHFFFAOYSA-N; [M+H]+; N-cyclohexylformamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.424; XFHJDMUEHUHAJW-UHFFFAOYSA-N; [M+H]+; N-tert-butylacrylamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.407; HMFQZRAOCARFRS-UHFFFAOYSA-N; [M+H]+; N-(3-methylbut-2-enyl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.402; ZAJDAGLJUKMNJL-JLDDOWRYNA-N; [M+H]+; Norhygrine;N-Demethylhygrine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.390; KDISMIMTGUMORD-UHFFFAOYSA-N; [M+H]+; 1-acetylpiperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.367; YYMCYJLIYNNOMK-UHFFFAOYNA-N; [M+H]+; Nor-psi-tropine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.350; PNZXMIKHJXIPEK-UHFFFAOYSA-N; [M+H]+; UNPD44931
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.345; YQIGLEFUZMIVHU-UHFFFAOYSA-N; [M+H]+; N-isopropylmethacrylamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.339; YARDEGUIPATLSG-UHFFFAOYSA-N; [M+H]+; 1,5,5-trimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.318; IVLICPVPXWEGCA-UHFFFAOYSA-N; [M+H]+; 3-quinuclidinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.303; RJLKIAGOYBARJG-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.268; YZZYFRBPGIXHPD-UHFFFAOYSA-N; [M+H]+; 1-(1-Pyrrolidinyl)-2-propanone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.266; ANJPRQPHZGHVQB-UHFFFAOYSA-N; [M+H]+; hexyl isocyanate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.261; VERUITIRUQLVOC-UHFFFAOYSA-N; [M+H]+; 2-butyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.239; DGPUVWXQJUQRCZ-UHFFFAOYSA-N; [M+H]+; 2-Acetonyl-3,5-dihydroxy-7-methoxy-1,4-naphthoquinone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.223; HHSKTLKGFHKHOI-UHFFFAOYSA-N; [M+H]+; 2-ethyl-1-(oxiran-2-ylmethyl)aziridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.199; XAZAHJGDOHGFBV-UHFFFAOYSA-N; [M+H]+; 7-hydroxyheptane-1-nitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.164; YEASGSCSOSLILK-UHFFFAOYSA-N; [M+H]+; 8-azabicyclo[3.2.1]octan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; HMFQZRAOCARFRS-UHFFFAOYSA-N; [M+H]+; N-(3-methylbut-2-enyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.751; IVLICPVPXWEGCA-UHFFFAOYSA-N; [M+H]+; 3-quinuclidinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.736; YEASGSCSOSLILK-UHFFFAOYSA-N; [M+H]+; 8-azabicyclo[3.2.1]octan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.694; VERUITIRUQLVOC-UHFFFAOYSA-N; [M+H]+; 2-butyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.693; RJLKIAGOYBARJG-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.664; ZAJDAGLJUKMNJL-JLDDOWRYNA-N; [M+H]+; Norhygrine;N-Demethylhygrine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.660; YARDEGUIPATLSG-UHFFFAOYSA-N; [M+H]+; 1,5,5-trimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.652; DGPUVWXQJUQRCZ-UHFFFAOYSA-N; [M+H]+; 2-Acetonyl-3,5-dihydroxy-7-methoxy-1,4-naphthoquinone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.645; ANJPRQPHZGHVQB-UHFFFAOYSA-N; [M+H]+; hexyl isocyanate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.607; KDISMIMTGUMORD-UHFFFAOYSA-N; [M+H]+; 1-acetylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.571; SWGXDLRCJNEEGZ-UHFFFAOYSA-N; [M+H]+; N-cyclohexylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.531; YYMCYJLIYNNOMK-UHFFFAOYNA-N; [M+H]+; Nor-psi-tropine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.485; PNZXMIKHJXIPEK-UHFFFAOYSA-N; [M+H]+; UNPD44931
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.417; XFHJDMUEHUHAJW-UHFFFAOYSA-N; [M+H]+; N-tert-butylacrylamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.392; HHSKTLKGFHKHOI-UHFFFAOYSA-N; [M+H]+; 2-ethyl-1-(oxiran-2-ylmethyl)aziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.336; YZZYFRBPGIXHPD-UHFFFAOYSA-N; [M+H]+; 1-(1-Pyrrolidinyl)-2-propanone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.333; YQIGLEFUZMIVHU-UHFFFAOYSA-N; [M+H]+; N-isopropylmethacrylamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.257; XAZAHJGDOHGFBV-UHFFFAOYSA-N; [M+H]+; 7-hydroxyheptane-1-nitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.351; PNZXMIKHJXIPEK-UHFFFAOYSA-N; [M+H]+; cyclohexanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.148; XFHJDMUEHUHAJW-UHFFFAOYSA-N; [M+H]+; N-tert-butylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.980; IVLICPVPXWEGCA-UHFFFAOYSA-N; [M+H]+; 1-azabicyclo[2.2.2]octan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.696; ZWXPDGCFMMFNRW-UHFFFAOYSA-N; [M+H]+; 1-methylazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.636; OVHHHVAVHBHXAK-UHFFFAOYSA-N; [M+H]+; N,N-diethylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.512; SWGXDLRCJNEEGZ-UHFFFAOYSA-N; [M+H]+; N-cyclohexylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.372; KDISMIMTGUMORD-UHFFFAOYSA-N; [M+H]+; 1-piperidin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.289; ANJPRQPHZGHVQB-UHFFFAOYSA-N; [M+H]+; 1-isocyanatohexane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.260; YRVUCYWJQFRCOB-UHFFFAOYSA-N; [M+H]+; N-butylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.204; OFEWIJHAUCILQY-UHFFFAOYSA-N; [M+H]+; 2-amino-1-cyclopentylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.204; CJYXCQLOZNIMFP-UHFFFAOYSA-N; [M+H]+; azocan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.181; VXJGQOYSBXKDRL-UHFFFAOYSA-N; [M+H]+; 2-(2-methylbut-3-yn-2-ylamino)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.159; YYMCYJLIYNNOMK-UHFFFAOYSA-N; [M+H]+; 8-azabicyclo[3.2.1]octan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.102; XTYKDEUKCJSSQJ-UHFFFAOYSA-N; [M+H]+; 2-prop-1-en-2-ylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; FOBOXLVXXYQTAK-UHFFFAOYSA-N; [M+H]+; 5-oxaspiro[3.4]octan-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; SZUYPFGFFGXXJN-UHFFFAOYSA-N; [M+H]+; 5-cyclopropyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; KUHIIBZROYQZJN-UHFFFAOYSA-N; [M+H]+; 5-oxaspiro[2.4]heptan-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; OXRCIXHTUHZNRY-UHFFFAOYSA-N; [M+H]+; 2-cyclopentylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; YXHVIDNQBMVYHQ-UHFFFAOYSA-N; [M+H]+; 1,5-dimethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.063; ZCGHPWOGZWDUHI-BNHYGAARSA-N; [M+H]+; (1S,5R,6R,7S)-7-aminobicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.062; SRPWFDSZEDKCPO-UHFFFAOYSA-N; [M+H]+; 2-aminospiro[3.3]heptan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; FPKONFBEIRRWPM-UHFFFAOYSA-N; [M+H]+; 4-cyclopropyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; ZWFBNNNANATSGE-UHFFFAOYSA-N; [M+H]+; methyl cyclopentanecarboximidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; OZRLVMQIQRNXEH-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[4.1.0]heptan-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; AAZVXZWIZSYZLN-UHFFFAOYSA-N; [M+H]+; 5-oxa-8-azaspiro[3.5]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; VOJNVOZYKCIITR-UHFFFAOYSA-N; [M+H]+; 2-cyclopropylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; GHELJWBGTIKZQW-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; KHEADQXFHZBJJQ-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)bicyclo[2.1.1]hexan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; VGXUJPLZZFLGKF-UHFFFAOYSA-N; [M+H]+; 1-methyl-2-oxabicyclo[3.1.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; FVHPPCBSLJVBQR-UHFFFAOYSA-N; [M+H]+; 2,3,4,4a,5,6,7,7a-octahydrocyclopenta[b][1,4]oxazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; WMRHLUMWSAZZMJ-LURJTMIESA-N; [M+H]+; [(6S)-5-azaspiro[2.4]heptan-6-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; CKGOIZORGVFPFX-RRKCRQDMSA-N; [M+H]+; [(1R,3S,4S)-2-azabicyclo[2.2.1]heptan-3-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; OMTDZTIZMPWNBU-RRKCRQDMSA-N; [M+H]+; (3S,3aS,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[b]pyrrol-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; KLFPQNHKRHERBF-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; PZVHOYQWDXQPIB-UHFFFAOYSA-N; [M+H]+; 5-azaspiro[2.5]octan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; XOVBBFFCGZNKSI-UHFFFAOYSA-N; [M+H]+; 5-azaspiro[3.4]octan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; FRGDHFVRTNWQJF-UHFFFAOYSA-N; [M+H]+; 6-azaspiro[3.4]octan-8-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; QCUYFULOPBGVDP-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; QJWGZYJFBDSKHF-UHFFFAOYSA-N; [M+H]+; 8-oxa-5-azaspiro[3.5]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.001; MPFQNPHIDITLTI-UHFFFAOYSA-N; [M+H]+; 7-oxa-4-azaspiro[2.6]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; DNXIQMQGKSQHPC-UHFFFAOYSA-N; [M+H]+; 7-methoxy-3,4,5,6-tetrahydro-2H-azepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; RRMNYNOYRVQRBY-UHFFFAOYSA-N; [M+H]+; 8-oxabicyclo[3.2.1]octan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.989; IJNIVGLVDMZFHZ-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; DQQMSJUCRWDLQE-UHFFFAOYSA-N; [M+H]+; 6-(methoxymethyl)-1,2,3,6-tetrahydropyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; XDAWFENPCDYKEA-UHFFFAOYSA-N; [M+H]+; 6-methylazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; ATKWPSUYYUWOKJ-QYNIQEEDSA-N; [M+H]+; (1S,2R,4S)-1-aminobicyclo[2.2.1]heptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.970; RMGNOCMBJZNUHH-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.2.2]octan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.970; SFMAUUPUQTZBRK-UHFFFAOYSA-N; [M+H]+; 6-oxabicyclo[3.2.1]octan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.970; OIQYPAWFNAOGKM-RNFRBKRXSA-N; [M+H]+; (1R,4R)-1-methyl-2-oxabicyclo[2.2.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; UHVAPMHYHSSGOJ-UHFFFAOYSA-N; [M+H]+; 7-oxabicyclo[2.2.1]heptan-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.967; YXQQMGSRJYROKV-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[3.1.1]heptan-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.967; JCOXLNNECBLFQE-UHFFFAOYSA-N; [M+H]+; 7-methoxy-5-azaspiro[2.4]heptane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; GZINBEIPEVMYOJ-UHFFFAOYSA-N; [M+H]+; 3-cyclopropyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; ITWKLSYEZRLYDF-RNFRBKRXSA-N; [M+H]+; [(1S,6R)-2-azabicyclo[4.1.0]heptan-1-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; ZZWFAKPWUUTAEQ-NKWVEPMBSA-N; [M+H]+; (4aR,7aS)-1,2,3,4,4a,5,7,7a-octahydrofuro[3,4-b]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; RJLKIAGOYBARJG-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.945; CEAFNAZSKXWJNK-UHFFFAOYSA-N; [M+H]+; (4-methyl-2-oxabicyclo[2.1.1]hexan-1-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; ADAVWIVNHOHLGV-BQBZGAKWSA-N; [M+H]+; (3aS,7aR)-2,3,3a,4,5,6,7,7a-octahydrofuro[2,3-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; ZPRYQRLMWOROKJ-UHFFFAOYSA-N; [M+H]+; (4-methyl-2-azabicyclo[2.1.1]hexan-1-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; VDDGQWSGGBMWQU-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylpyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; ROZOWQBTMUUFPZ-UHFFFAOYSA-N; [M+H]+; 1-azabicyclo[3.2.1]octan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; HCWAPSMTWACPRW-UHFFFAOYSA-N; [M+H]+; 3,5,6,7,8,8a-hexahydro-1H-[1,3]oxazolo[3,4-a]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; MSIYFEZKZBCLQM-UHFFFAOYSA-N; [M+H]+; 5-methyl-5-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.930; DVVZRIIREIUXSR-UHFFFAOYSA-N; [M+H]+; 3-oxa-9-azabicyclo[3.3.1]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; RVUBHWGJRCJPSK-RRKCRQDMSA-N; [M+H]+; (3aS,6R,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[b]pyrrol-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; NZPQUUKDWPIDAW-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[3.1.1]heptan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; HTALZFBPQOAZAO-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[3.2.0]heptan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.921; OEXOIRGCCGITRX-UHFFFAOYSA-N; [M+H]+; 7-oxa-2-azabicyclo[3.3.1]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; WTHAVLKCRJPDGR-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.2.2]octan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; BUBVVQHRVJCXFR-UHFFFAOYSA-N; [M+H]+; 7-azabicyclo[2.2.1]heptan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; FNUPMUAERHXXKO-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.2.1]heptan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; AOYUQKRGAQMSJV-UHFFFAOYSA-N; [M+H]+; 8-azabicyclo[3.2.1]octan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; GUDDYFAFCAXQLA-UHFFFAOYSA-N; [M+H]+; 9-oxa-3-azabicyclo[3.3.1]nonane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; HRPBDLJQDPPYMV-UHFFFAOYSA-N; [M+H]+; 3-cyclobutylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; GKILKXYVPBASLE-BQBZGAKWSA-N; [M+H]+; [(2S,3S)-2-ethenyloxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; VJBMPVPFRKUUFP-RQJHMYQMSA-N; [M+H]+; (2R,4R)-2-ethenyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; IGQVSVIYRURIET-UHFFFAOYSA-N; [M+H]+; 1-methylcyclopentane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.881; POBRGJPTUPPFOR-UHFFFAOYSA-N; [M+H]+; 4-ethenyloxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; AWVNJBFNHGQUQU-UHFFFAOYSA-N; [M+H]+; 3-butoxypropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; AGGSGTDKCCRCNB-UHFFFAOYSA-N; [M+H]+; 2-aminocycloheptan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; STNLQJRBZHAGSO-UHFFFAOYSA-N; [M+H]+; 1-piperidin-4-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; CRIKMINAHWLNMK-UHFFFAOYSA-N; [M+H]+; 1-(1-aminocyclopentyl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.853; NPESJLMSOHJUQQ-UHFFFAOYSA-N; [M+H]+; 1-piperidin-3-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; ZAJDAGLJUKMNJL-UHFFFAOYSA-N; [M+H]+; 1-pyrrolidin-2-ylpropan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; SUSANAYXICMXBL-UHFFFAOYSA-N; [M+H]+; 4-prop-2-enylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; BDVKAMAALQXGLM-UHFFFAOYSA-N; [M+H]+; 1-ethylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.832; PAHMYIHLZQRVHU-UHFFFAOYSA-N; [M+H]+; 6-ethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.832; MRFIPTCIQWTHBC-UHFFFAOYSA-N; [M+H]+; 4-(methoxymethyl)-1,2,3,6-tetrahydropyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.828; JNWLFMYCGXLVJQ-SSDOTTSWSA-N; [M+H]+; (2R)-2-isocyanatohexane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.828; YQIGLEFUZMIVHU-UHFFFAOYSA-N; [M+H]+; 2-methyl-N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.827; OALIFKZSZCONPI-UHFFFAOYSA-N; [M+H]+; 3-ethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; FGSUUFDRDVJCLT-UHFFFAOYSA-N; [M+H]+; 3-methylazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.821; OUAYHRAFRHTWGZ-UHFFFAOYSA-N; [M+H]+; 2-aminospiro[3.3]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.820; MNSBKXZGNNQYBX-UHFFFAOYSA-N; [M+H]+; 5-oxaspiro[3.4]octan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.819; RZAVDURPAHGGQM-UHFFFAOYSA-N; [M+H]+; 6-oxaspiro[3.4]octan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.819; BSESSGRISLUQGE-UHFFFAOYSA-N; [M+H]+; 5-oxaspiro[2.4]heptan-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.818; BGDGMIWDPMJYPP-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; FWDUYTVEXNTPGQ-UHFFFAOYSA-N; [M+H]+; (2-amino-1-bicyclo[3.1.0]hexanyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; PCSOIFCXHXFRPF-UHFFFAOYSA-N; [M+H]+; 4-ethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -87.241; KDISMIMTGUMORD; [M+H]+; N-Acetylpiperidin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -94.981; LZDUSDGRALPEID; [M+H]+; 5,5-dimethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -109.422; XDAWFENPCDYKEA; [M+H]+; 6-Methylcaprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.059; IGQVSVIYRURIET; [M+H]+; Enamine_000234
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.665; ANJPRQPHZGHVQB; [M+H]+; hexanisocyanate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -114.294; CJYXCQLOZNIMFP; [M+H]+; 2-Azocanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -114.735; DTOQVACKCYCLKA; [M+H]+; 4,4-dimethylpiperidine-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.989; LVYOYMNCAWSORG; [M+H]+; 4-Piperidinone, 2,6-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.818; STNLQJRBZHAGSO; [M+H]+; 1-(Piperidin-4-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -121.044; ZJIPQXKCGKZAKM; [M+H]+; 3-ethyl-3-methylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.501; RMCKFEFIZJHSCL; [M+H]+; 3-(isocyanatomethyl)pentane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -125.567; PCSOIFCXHXFRPF; [M+H]+; 4-ethylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -125.979; SUXWXEJDQZBDNL; [M+H]+; 4-Methylcaprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -127.924; OVHHHVAVHBHXAK; [M+H]+; N,N-Diethylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -129.913; YQIGLEFUZMIVHU; [M+H]+; N-Isopropylmethacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.067; ZAJDAGLJUKMNJL; [M+H]+; 2-Propanone,1-(2-pyrrolidinyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.911; PNZXMIKHJXIPEK; [M+H]+; ACMC-20alcz
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.607; YWJNZEJGGLBELP; [M+H]+; 4-isopropylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.538; BDVKAMAALQXGLM; [M+H]+; 1-Ethyl-4-piperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.993; XFHJDMUEHUHAJW; [M+H]+; tert-Butylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.613; UIHSTNXWLQMGGF; [M+H]+; 3,3,5-trimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.558; OXRCIXHTUHZNRY; [M+H]+; Cyclopentaneacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.814; SWGXDLRCJNEEGZ; [M+H]+; bmse000630
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.959; UDMMJJYIAHHNQA; [M+H]+; 1-Ethyl-3-piperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.835; XHMUOLXEAFNULF; [M+H]+; 3,3-Dietil-2-azetidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.421; GHELJWBGTIKZQW; [M+H]+; N-Isopropylbutyrolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.486; YZZYFRBPGIXHPD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.386; JZTDQNCGEQOQLX; [M+H]+; 2-Pyrrolidinecarboxaldehyde, 1-ethyl-, (2S)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.180; SUSANAYXICMXBL; [M+H]+; Allylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.247; RJLKIAGOYBARJG; [M+H]+; dimethylpiperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.443; RECARUFTCUAFPV; [M+H]+; 2-Oxa-7-azaspiro[3.5]nonane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.161; NGIZWTLYXYMEFV; [M+H]+; 3-propan-2-ylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.653; ZWXPDGCFMMFNRW; [M+H]+; 1-Methylcaprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.964; AIPVTTKYSPOWFO; [M+H]+; azepane-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.668; OENGSNXUALAIFP; [M+H]+; Suberoxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.622; SDESQEIYRGXXPA; [M+H]+; 2-Oxa-6-azaspiro[3.5]nonane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.188; YXHVIDNQBMVYHQ; [M+H]+; 1,5-Dimethyl-2-piperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.075; VOJNVOZYKCIITR; [M+H]+; 2-cyclopropylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.927; LKIYWJKEOOFVCV; [M+H]+; 1-methylpiperidine-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.675; FNTBEHJVXDDFRG; [M+H]+; 2-Oxa-5-azaspiro[3.5]nonane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.709; AAZVXZWIZSYZLN; [M+H]+; 5-oxa-8-azaspiro[3.5]nonane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.044; DGPUVWXQJUQRCZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.305; DZFZYIQSJQMOHP; [M+H]+; 1-Formyl-3-methylpiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.248; AYLRAYHEVWKPPS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.307; AWVNJBFNHGQUQU; [M+H]+; 3-Butoxypropannitril
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.685; BGDGMIWDPMJYPP; [M+H]+; zlchem 321
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.713; YYMCYJLIYNNOMK; [M+H]+; Nortropin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.627; XAZAHJGDOHGFBV; [M+H]+; 6-Cyano-1-hexanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.107; PHLODXGIZNXWBL; [M+H]+; 3-isobutoxypropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.137; MDIFHVYPHRHKLB; [M+H]+; 2-Methylcyclohexanone oxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.934; LPRMANDJSIXLBP; [M+H]+; 5-Hydroxy-4,4-dimethylvaleronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.117; YWWQFUDBRVWOJV; [M+H]+; Ambpe2001896
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.480; YARDEGUIPATLSG; [M+H]+; 1,5,5-trimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.306; CKGOIZORGVFPFX; [M+H]+; 2-azabicyclo[2.2.1]heptan-3-ylmethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.362; UGQAXUDFJWQPHM; [M+H]+; 2-Oxa-7-azaspiro[4.4]nonane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.046; QGNOEKXMUHRRJA; [M+H]+; 2,5,5-Trimethyl-1-pyrroline N-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.675; DNXIQMQGKSQHPC; [M+H]+; O-Methylcaprolactim
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.377; HCWAPSMTWACPRW; [M+H]+; 2-Oxaindolizidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.734; BUBVVQHRVJCXFR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.011; DWZKXPAWEWMLEJ; [M+H]+; 2-Hydroxy-2,4-dimethylvaleronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.787; FGURMUFTHTVTAL; [M+H]+; ACMC-20anwm
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.448; WIUNXKVGEVWUPY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.436; OPGYNKVUGYWXQA; [M+H]+; 2-hydroxyethyl-dimethyl-prop-2-ynylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.929; IVLICPVPXWEGCA; [M+H]+; Quinuclidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.927; XCZCVUOQSMDKQW; [M+H]+; 1,2,3,6-Tetrahydro-1-methylpyridine-4-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.273; KDISMIMTGUMORD; [M+H]+; N-Acetylpiperidin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.415; WJPJTFLYZKXIOV; [M+H]+; N-(2-cyclopropylethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -86.722; MPZOKWUECDYCHY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.880; PDRLIRDRGUGZCE; [M+H]+; N-(cyclobutylmethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -99.283; WLCAZJJFEUYGSM; [M+H]+; N-(1-methylcyclobutyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.099; SBYMYORKPNSHTN; [M+H]+; N-(2-ethylcyclopropyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.861; JTSGEWHPQPAXOR; [M+H]+; N-Cyclopentylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.723; RYZYZGWZFAGHCV; [M+H]+; N-(5-Heptynyl)hydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.853; VFBLBGAHFZMOIO; [M+H]+; (1S)-1-[(E)-cyclopropylmethylideneamino]propan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -115.373; GRNFHSGFIGDFSE; [M+H]+; N-(4-Pentenyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.857; BDSFWCKDQOCPGE; [M+H]+; N-(1-cyclopropylethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.266; WJPJTFLYZKXIOV; [M+H]+; N-(2-cyclopropylethyl)acetamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H14N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.604
MS$FOCUSED_ION: PRECURSOR_M/Z 128.106975
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00pi-9500000000-8e32f91ca6a154e626e8
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388121 72.0359 53.039510 1.0747 24.99 -0.0212 29 f{C4H5}/4.44ppm,p-C3H9N1O1
  55.0180865 54.0561 55.018794 1.3087 16.69 0.1980 29 f{C3H3O1}/4.46ppm,p-C4H11N1
  55.0545122 372.9543 55.055220 0.5812 98.64 0.2992 40 f{C4H7}/5.19ppm,p-C3H7N1O1
  56.0496778 58.6235 56.050390 1.3381 21.12 -0.3877 31 f{C3H6N1}/3.61ppm,p-C4H8O1
  57.0336837 59.7048 57.034400 1.2273 17.33 0.2587 33 f{C3H5O1}/3.38ppm,p-C4H9N1
  57.0700935 125.0167 57.070810 0.9812 32.33 0.3113 40 f{C4H9}/3.80ppm,p-C3H5N1O1
  58.0653797 281.8222 58.066100 0.7750 53.87 0.7300 40 f{C3H8N1}/4.38ppm,p-C4H6O1
  60.0446379 677.5739 60.045365 0.4497 51.69 0.9690 40 f{C2H6N1O1}/4.12ppm,p-C5H8
  67.0543485 79.2208 67.055090 1.2676 26.09 0.0807 40 f{C5H7}/1.82ppm,p-C2H7N1O1
  69.0335670 67.0122 69.034310 1.1009 23.85 0.3112 35 f{C4H5O1}/1.10ppm,p-C3H9N1
  69.0700370 629.4020 69.070780 0.3330 63.01 0.9388 40 f{C5H9}/2.32ppm,p-C2H5N1O1
  71.0492468 85.6186 71.049990 0.9993 28.32 0.1860 35 f{C4H7O1}/1.49ppm,p-C3H7N1
  79.0542978 70.2847 79.055030 1.0499 24.69 0.2504 35 f{C6H7}/0.90ppm,p-C1H7N1O1
  80.9451232 565.4788 80.945850 0.5559 134.69 0.1638 40 ?
  81.0335459 53.2173 81.034272 1.3575 12.99 0.5808 29 f{C5H5O1}/0.68ppm,p-C2H9N1
  81.0699236 195.9491 81.070650 0.9991 47.93 0.3293 40 f{C6H9}/0.58ppm,p-C1H5N1O1
  82.0651469 123.2855 82.065870 1.1211 50.21 -0.2188 40 f{C5H8N1}/0.26ppm,p-C2H6O1
  83.0491705 98.0368 83.049890 0.9512 38.14 0.2708 38 f{C5H7O1}/0.35ppm,p-C2H7N1
  83.0855806 321.4220 83.086300 0.8425 87.83 0.2525 40 f{C6H11}/0.65ppm,p-C1H3N1O1
  84.0443944 82.7659 84.045110 1.0471 26.58 0.1988 29 f{C4H6N1O1}/0.05ppm,p-C3H8
  84.9597382 69.3740 84.960450 1.3065 26.33 0.0247 36 ?
  85.0284285 77.5715 85.029140 1.3525 24.77 0.3023 37 ?
  85.0648487 74.4538 85.065560 1.1873 52.31 -0.0436 31 f{C5H9O1}/0.67ppm,p-C2H5N1
  86.0059129 105.8829 86.006620 1.3836 33.81 0.1720 40 ?
  97.0076473 116.0833 97.008285 1.1442 43.24 0.1125 32 ?
  100.0757081 144.5910 100.076320 1.1591 35.47 0.5919 40 f{C5H10N1O1}/0.18ppm,p-C2H4
  109.0284109 79.9992 109.028940 1.1557 23.68 0.2535 38 ?
  116.9662032 664.2398 116.966670 0.4360 165.69 0.0073 40 ?
  127.0390720 357.5330 127.039440 0.8344 172.68 0.0477 40 ?
  128.0620383 68.7747 128.062395 1.1557 19.74 0.0857 34 ?
  128.0706784 135.7831 128.071035 1.1868 41.38 -0.0916 40 ?
  128.1070538 999.0000 128.107410 0.4059 0.00 1.0000 40 f{C7H14N1O1}/0.49ppm,p
  128.9865737 77.5302 128.986920 1.4110 26.30 -0.0325 38 ?
  129.0699425 62.0687 129.070288 1.2551 14.71 0.4079 29 ?
  129.1104651 90.8168 129.110810 0.8597 13.60 0.8952 31 ?
  130.0651510 146.9347 130.065485 1.3609 85.74 0.4069 32 ?
PK$NUM_PEAK: 36
PK$PEAK: m/z int. rel.int.
  53.038812 72.04 72
  55.018086 54.06 54
  55.054512 372.95 372
  56.049678 58.62 58
  57.033684 59.70 59
  57.070094 125.02 125
  58.065380 281.82 281
  60.044638 677.57 677
  67.054348 79.22 79
  69.033567 67.01 67
  69.070037 629.40 629
  71.049247 85.62 85
  79.054298 70.28 70
  80.945123 565.48 565
  81.033546 53.22 53
  81.069924 195.95 195
  82.065147 123.29 123
  83.049170 98.04 98
  83.085581 321.42 321
  84.044394 82.77 82
  84.959738 69.37 69
  85.028429 77.57 77
  85.064849 74.45 74
  86.005913 105.88 105
  97.007647 116.08 116
  100.075708 144.59 144
  109.028411 80.00 79
  116.966203 664.24 664
  127.039072 357.53 357
  128.062038 68.77 68
  128.070678 135.78 135
  128.107054 999.00 999
  128.986574 77.53 77
  129.069943 62.07 62
  129.110465 90.82 90
  130.065151 146.93 146
//
